Consultations
| The code | Designation | Price |
| 01.01.001 | Consultation of a doctor of medical sciences, professors | 3500 |
| 01.01.002 | Repeated consultation of a doctor of medical sciences, professors | 2000 |
| 02.01.065 | The provision of medical rehabilitation services using telemedicine technologies | 3 300 |
| 02.01.001 | Admission (inspection, consultation) obstetrician-gynecologist | 2 500 |
| 02.01.002 | Repeated reception (inspection, consultation) obstetrician-gynecologist | 1 800 |
| 02.01.004 | Admission (inspection, consultation) allergist- immunologist | 2 500 |
| 02.01.005 | Repeated reception (inspection, consultation) allergist- immunologist | 1 800 |
| 02.01.007 | Admission (inspection, consultation) gastroenterologist | 2 500 |
| 02.01.008 | Repeated reception (inspection, consultation) gastroenterologist | 1 800 |
| 02.01.010 | Admission (inspection, consultation) dermatovenereologist | 2 500 |
| 02.01.011 | Repeated reception (inspection, consultation) dermatovenereologist | 1 800 |
| 02.01.013 | Admission (inspection, consultation) nutritionist | 2 500 |
| 02.01.014 | Repeated reception (inspection, consultation) nutritionist | 1 800 |
| 02.01.016 | Admission (inspection, consultation) cardiologist | 2 500 |
| 02.01.017 | Repeated reception (inspection, consultation) cardiologist | 1 800 |
| 02.01.019 | Admission (inspection, consultation) physiotherapy doctor | 2 500 |
| 02.01.020 | Repeated reception (inspection, consultation) physiotherapy doctor | 1 800 |
| 02.01.022 | Admission (inspection, consultation) doctor- reflexologist | 2 500 |
| 02.01.023 | Repeated reception (inspection, consultation) doctor- reflexologist | 1 800 |
| 02.01.025 | Admission (inspection, consultation) neurologist | 2 500 |
| 02.01.026 | Repeated reception (inspection, consultation) neurologist | 1 800 |
| 02.01.028 | Admission (inspection, consultation) doctor- chiropractor | 2 500 |
| 02.01.029 | Repeated reception (inspection, consultation) doctor- chiropractor | 1 800 |
| 02.01.031 | Admission (inspection, consultation) oncologist | 2 500 |
| 02.01.032 | Repeated reception (inspection, consultation) oncologist | 1 800 |
| 02.01.034 | Admission (inspection, consultation) ophthalmologist | 2 500 |
| 02.01.035 | Repeated reception (inspection, consultation) ophthalmologist | 1 800 |
| 02.01.037 | Admission (inspection, consultation) otorhinolaryngologist | 2 500 |
| 02.01.038 | Repeated reception (inspection, consultation) otorhinolaryngologist | 1 800 |
| 02.01.040 | Admission (inspection, consultation) pulmonologist | 2 500 |
| 02.01.041 | Repeated reception (inspection, consultation) pulmonologist | 1 800 |
| 02.01.043 | Admission (inspection, consultation) doctor- rehabilitator | 2 500 |
| 02.01.044 | Repeated reception (inspection, consultation) doctor- rehabilitator | 1 800 |
| 02.01.046 | Admission (inspection, consultation) general practitioner | 2 500 |
| 02.01.047 | Repeated reception (inspection, consultation) general practitioner | 1 800 |
| 02.01.049 | Admission (inspection, consultation) urologist | 2 500 |
| 02.01.050 | Repeated reception (inspection, consultation) urologist | 1 800 |
| 02.01.052 | Admission (inspection, consultation) physiotherapist | 2 500 |
| 02.01.053 | Repeated reception (inspection, consultation) physiotherapist | 1 800 |
| 02.01.055 | Admission (inspection, consultation) surgeon | 2 500 |
| 02.01.056 | Repeated reception (inspection, consultation) surgeon | 1 800 |
| 02.01.058 | Admission (inspection, consultation) endocrinologist | 2 500 |
| 02.01.059 | Repeated reception (inspection, consultation) endocrinologist | 1 800 |
| 02.01.061 | Admission (inspection, consultation) infectious disease doctor | 2 500 |
| 02.01.062 | Repeated reception (inspection, consultation) infectious disease doctor | 1 800 |
| 02.01.064 | Television consultation of a specialist doctor | 2 200 |
| 02.01.066 | Admission (inspection, consultation) anesthesiologist-resuscitator | 2 500 |
| 02.01.067 | Repeated reception (inspection, consultation) anesthesiologist-resuscitator | 1 800 |
| 02.01.068 | Admission (inspection, consultation) The psychiatrist is primary | 2 500 |
| 02.01.069 | Admission (inspection, consultation) A psychiatrist is repeated | 1 800 |
| 02.01.070 | Admission (inspection, consultation) Geriater is primary | 2 500 |
| 02.01.071 | Admission (inspection, consultation) A heroist doctor is repeated | 1 800 |
| 02.01.072 | Admission (inspection, consultation) Psychotherapist is primary | 2 500 |
| 02.01.073 | Admission (inspection, consultation) A psychotherapist is repeated | 1 800 |
| 02.01.064 | Television consultation of a specialist doctor | 2 200 |
Programs
| The code | Designation | Price |
| 13.02.001 | Complex diagnosis and treatment: Holecystectomy is laparoscopic | 60 390 |
| 13.02.002 | PRRAGRAM TREATE OPISTORKOZA | 20 000 |
| 14.01.001 | Accommodation 1 categories , 1 bed-day | 3000 |
| 14.01.002 | Accommodation 2 categories, 1 bed-day | 4000 |
| 14.01.003 | Accommodation 3 categories, 1 bed-day | 4500 |
| 14.01.006 | Stay in the ward of the intensive care unit and intensive therapy, 1 bed-day | 6000 |
| 14.01.009 | Individual medical care and patient support, 1 bed-day | 2500 |
| 14.01.010 | A daily examination by the oncologist with the supervision and care of the average and junior medical personnel in the hospital department, 1 bed-day | 4000 |
| 14.01.011 | Stay in the ward 3 categories, Single placement, 1 bed-day | 6750 |
Specialized assistance
| The code | Designation | Price |
| 1 | GYNECOLOGY | |
| 03.01.001 | Obtaining a smear from the cervix | 250 |
| 03.01.002 | The introduction of drugs intravaginal drugs | 250 |
| 03.01.003 | Tamponing therapeutic vagina | 250 |
| 03.01.004 | Removal of an intrauterine spiral | 2 200 |
| 03.01.005 | The introduction of an intrauterine spiral | 2 800 |
| 03.01.006 | Cauterization of cervical erosion with drugs (excluding the cost of the medicine) | 330 |
| 03.01.007 | Cauterization of condille with medicines (1 element) | 770 |
| 03.01.008 | Treatment of genital prolapse (1 categories) | 7 370 |
| 03.01.009 | Treatment of genital prolapse (2 categories) | 9 680 |
| 03.01.010 | Colposcopy | 1 500 |
| 03.01.011 | Biopsy of the cervix | 2 800 |
| 2 | UROLOGY | |
| 03.02.001 | Cystoscopy | 3 000 |
| 03.02.002 | Collection of the secret of the prostate | 880 |
| 03.02.003 | Prostate massage | 1 000 |
| 03.02.004 | Urethra instillation | 900 |
| 03.02.005 | The instillation of the bladder | 900 |
| 03.02.006 | Material fence for strokes | 350 |
| 03.02.007 | Material fence for bacter | 350 |
| 03.02.008 | Material fence for research by PCR | 350 |
| 3 | Oncology and chemotherapy | |
| 03.03.001 | The prescription of drugs for oncological disease in adults (paclitaxel) | 35 000 |
| 7 | Dermatology | |
| 03.07.001 | Skin examination under an increase (Dermatoscopy) | 600 |
| 8 | Otorhinolaryngology | |
| 03.08.001 | Treatment on the device "Tonsilor", 1 procedure | 800 |
| 03.08.002 | Exposure to alternating magnetic field for diseases of the upper respiratory tract | 350 |
| 03.08.003 | Intra -regional injections, 1 procedure | 600 |
| 03.08.004 | The introduction of drugs intranasally | 450 |
| 03.08.005 | Rinse of the paranasal sinuses and nasopharynx | 600 |
| 03.08.006 | Greenhouse blockade with the introduction of drugs | 600 |
| 03.08.022 | Inside blockade | 600 |
| 03.08.007 | Removing ear sulfur | 500 |
| 03.08.019 | Removal of sulfur plug washing the auditory passage | 600 |
| 03.08.020 | Opening of a faint follicle tonsil of tonsils | 900 |
| 03.08.008 | Blowing the auditory pipe | 450 |
| 03.08.009 | Taping tonsils | 800 |
| 03.08.010 | Listen blockade with drugs | 700 |
| 03.08.011 | Introduction of drugs into the external auditory passage | 400 |
| 03.08.012 | Obtaining smears from the mucous membrane of the nasopharynx | 150 |
| 03.08.023 | Obtaining strokes from the mucous membrane of the oropharynx | 150 |
| 03.08.013 | The fence of the separated from the ear to bacteriological sowing | 150 |
| 03.08.021 | Pneumatic massage of the eardrum(With the help of a pneumatic massager) | 550 |
| 03.08.024 | Electro -Audiometry (Pronmontian test) | 400 |
| 03.08.014 | Stewing the mucous membrane of the back wall of the pharynx or palatine tonsils 10% silver nitrate solution | 300 |
| 03.08.015 | Stewing the mucous membrane of the back wall of the pharynx or palatine tonsils 30% silver nitrate solution | 550 |
| 03.08.016 | Stewing vessels of the nasal septum 30% silver nitrate solution | 300 |
| 03.08.017 | Vestibular test | 700 |
| 9 | OPHTHALMOLOGY | |
| 03.09.001 | Visometry | 400 |
| 03.09.002 | The perimetry is static | 450 |
| 03.09.003 | Ophthalmotonometry | 450 |
| 03.09.004 | Study of the front segment of the eye method of lateral lighting | 220 |
| 03.09.010 | Selection of point vision correction | 275 |
| 03.09.005 | Scraping conjunctiva | 150 |
| 03.09.006 | Ophthalmoscopy | 400 |
| 03.09.007 | Biomicroscopy of the eye | 350 |
| 03.09.008 | Massage is medical | 350 |
| 03.09.009 | Study of the front segment of the eye method of lateral lighting | 220 |
| 10 | NEUROLOGY | |
| 03.10.001 | Miastenia examination program (primary) | 5 000 |
| 03.10.002 | Miastenia examination program (therapy correction) | 4 000 |
| 03.10.005 | Examination program for headache (primary) | 4 500 |
| 03.10.006 | Examination program for headache (therapy correction) | 3 500 |
| 11 | Extracorporeal therapy | |
| 03.11.001 | Plasmapheresis is discrete | 10 000 |
| 03.11.002 | Ultraviolet irradiation of blood | 600 |
| 03.11.003 | Low -intensity laser therapy (intravenous blood irradiation) | 500 |
| 03.11.004 | Laser (external exposure) | 500 |
| 03.11.005 | Plasmapherez membrane | 10 000 |
| 03.11.006 | Hemoexfusion (bloodletting) | 1 000 |
| 03.11.007 | Lipid filtering | 150 000 |
| 12 | Anesthesiological aids | |
| 03.12.001 | Total intravenous anesthesia (EGDS + colonoscopy) | 5 000 |
| 03.12.002 | Total intravenous anesthesia | 5 000 |
| 03.12.003 | Automated electromiostimulation with verticalization | 715 |
| 03.12.004 | Infiltration anesthesia | 1 000 |
| 03.12.005 | Epidural anesthesia | 15 000 |
| 13 | Genetical and engineering therapy | |
| 03.13.001 | Treatment of Crohn's disease with igibators of the tumor necrosis factor before 60 kg (Infliximab) | 61 000 |
| 03.13.002 | Treatment of Crohn's disease with igibators of the tumor necrosis factor before 70 kg (Infliximab) | 77 000 |
| 03.13.003 | Treatment of Crohn's disease with igibators of the tumor necrosis factor before 80 kg (Infliximab) | 94 000 |
| 03.13.004 | Treatment of chronic polypose rhinitis with recombinant monoclonal antibodies (Dupilumab) | 61 000 |
| 03.13.005 | Treatment of hypercholesterolemia (Embedded) | 165 000 |
| 03.13.006 | Treatment of hypercholesterolemia (Alirocumab) 75 mg | 22 000 |
| 03.13.007 | Treatment of hypercholesterolemia (Alirocumab) 150 mg | 44 000 |
| 03.13.008 | Treatment of hypercholesterolemia (Alirocumab) 300 mg | 55 000 |
| 14 | SURGERY | |
| 03.14.001 | Hernias with a hernia of the white line of the abdomen (Light shape) excluding the cost of mesh implant | 35 000 |
| 03.14.002 | Hernias with a hernia of the white line of the abdomen (Light shape) Taking into account the cost of mesh implant | 40 000 |
| 03.14.003 | Operation with a small and medium postoperative hernia (without the use of mesh implants) | 35 000 |
| 03.14.004 | Surgical treatment of postoperative hernia using mesh implants | 40 000 |
| 03.14.005 | Surgical treatment of umbilical hernia | 35 000 |
| 03.14.006 | Surgical treatment of umbilical hernia using mesh implants | 45 000 |
| 03.14.007 | Surgical treatment of umbilical hernia using video endoscopic technologies (without the use of mesh implants) | 50 000 |
| 03.14.008 | Surgical treatment of umbilical hernia using video endoscopic technologies (using mesh implants) | 55 000 |
| 03.14.009 | Surgical treatment | 35 000 |
| 03.14.010 | Surgical treatment of arablenial hernia using mesh implants | 45 000 |
| 03.14.011 | Surgical treatment of arablenial hernia using video endoscopic technologies (without the use of mesh implants) | 50 000 |
| 03.14.012 | Surgical treatment of arablenial hernia using video endoscopic technologies (using mesh implants) | 55 000 |
| 03.14.013 | Surgical treatment of hernia of the anterior abdominal wall (excluding the cost of mesh implants) | 35 000 |
| 03.14.014 | Surgical treatment of hernia of the anterior abdominal wall using mesh implants | 45 000 |
| 03.14.015 | Operation with a large postoperative hernia (Bespol -use of mesh implants) | 35 000 |
| 03.14.016 | Operation with a large postoperative hernia using mesh implants | 45 000 |
| 03.14.017 | Operation with a large postoperative hernia using video endoscopic technologies (without the use of mesh implants) | 50 000 |
| 03.14.018 | Operation with a large postoperative hernia using video endoscopic technologies (using mesh implants) | 55 000 |
| 03.14.019 | Operation with a giant postoperative hernia (without the use of mesh implants) | 45 000 |
| 03.14.020 | Surgery with a giant postoperative hernia using mesh implants | 55 000 |
| 03.14.021 | Operation with a giant postoperative hernia using video endoscopic technologies (without the use of mesh implants) | 60 000 |
| 03.14.022 | Operation with a giant postoperative hernia using video endoscopic technologies (using mesh implants) | 80 000 |
| 03.14.023 | Cholecystectomy | 40 000 |
| 03.14.024 | Holecystectomy is laparoscopic | 45 000 |
| 03.14.025 | Removal of benign neoplasms of subcutaneous fat | 7 480 |
| 03.14.026 | Appendectomy | 40 000 |
| 03.14.027 | Appendectomy using video endoscopic technologies | 50 000 |
| 03.14.028 | Diagnostic laparoscopy | 30 000 |
| 03.14.029 | Splenectomy using video endosurgical technologies | 60 000 |
| 03.14.030 | Putting secondary seams | 5 000 |
| 03.14.031 | Removal of atheroma | 6 000 |
| 03.14.032 | Removal of atheroma (large) | 8 000 |
| 03.14.033 | Removal of benign skin neoplasms to 2 cm | 3 300 |
| 03.14.034 | Removal of benign skin neoplasms from 2 to 4 cm | 4 730 |
| 03.14.035 | Removing benign leafy skin from above 4 cm | 6 600 |
| 03.14.036 | Sigmoid colon resection using video endoscopic technologies | 110 000 |
| 03.14.037 | Hemiccoctomy is left -handed | 80 000 |
| 03.14.038 | Hemicolectomy left -handed using video endoscopic technologies (excluding the sewing apparatus) | 60 000 |
| 03.14.039 | Hemicolectomy left -handed using video endoscopic technologies | 110 000 |
| 03.14.040 | Removal of hemorrhoids | 20 000 |
| 03.14.041 | Epithelial coccygeal excision | 20 000 |
| 03.14.042 | Cutting stomach or duodenal ulcers | 30 000 |
| 03.14.043 | Excision of stomach ulcers or duodenum | 30 000 |
| 03.14.044 | Laying a bandage in violation of the integrity of the skin | 1 000 |
| 03.14.045 | Removing benign leather neoplasms by electrocoagulation (papilloma; per unit) | 770 |
| 03.14.046 | Removing benign leather neoplasms by electrocoagulation (wart; per unit) | 1 540 |
| 03.14.047 | Removing benign leather neoplasms by electrocoagulation (wart; per unit) | 1 760 |
| 03.14.048 | Surgical wound treatment or infected tissue (Pho Ran) | 10 000 |
| 03.14.049 | Opening of soft tissue hematoma | 4 510 |
| 03.14.050 | Removal of a superficial -located foreign body (without dissection of fabrics) | 1 375 |
| 03.14.051 | Removal of a foreign body with dissection of soft tissues | 4 620 |
| 03.14.052 | Removal of exostosis, chondroma (Fibroma, Hygroms) | 10 340 |
| 03.14.053 | Removal of postoperative seams (Ligatur) | 1 100 |
| 03.14.054 | Longitudinal resection of the stomach laparoscopic | 330 000 |
Massage
| The code | Designation | Price |
| 04.03.030 | Vibrational impact (Vibration massage) (Massage unit - 1 region 10 minutes) | 440 |
| 04.03.032 | Vibration massage of the upper limb | 660 |
| 04.03.033 | Vibration massage of the upper limb, shoulder streams and spatulas | 880 |
| 04.03.031 | Vibration massage of the collar zone (The posterior surface of the neck, back to level IV breast vertebra, anterior surface of the chest to II rib) | 660 |
| 04.03.050 | Vibration massage of the ankle joint (proximal footing, areas of the ankle joint and lower third of the lower leg) | 880 |
| 04.03.037 | Vibration massage of the hand and forearm | 440 |
| 04.03.049 | Vibration massage of the knee joint (The upper third of the lower leg, the knee joint and lower third of the thigh) | 880 |
| 04.03.035 | Vibration massage of the elbow joint (The upper third of the shoulder, area of the elbow joint and lower third of the shoulder) | 440 |
| 04.03.036 | Vibration massage of the wrist joint (proximal brush, wrist joints and forearms) | 440 |
| 04.03.046 | Vibration massage of the lower limb | 660 |
| 04.03.047 | Vibration massage of the lower limb and lower back (foot areas, shin, hips, gluteal and lumbosacral region) | 880 |
| 04.03.038 | Vibration massage of the chest area (areas of the anterior surface of the chest from the front boundaries of the shoulders to rib arches and the back of the back | 1 100 |
| 04.03.045 | Vibration massage of the spine area (The posterior surface of the neck, back and lumbosacral region from the left to the right rear axillary line) | 1 100 |
| 04.03.034 | Vibration massage of the shoulder joint (The upper third of the shoulder, areas of the shoulder joint and the shoulder of the side of the same name) | 440 |
| 04.03.040 | Vibration massage of the lumbosacral region (from I lumbar vertebra to the lower gluteal folds) | 550 |
| 04.03.039 | Vibration back massage (from the VIII cervical to I lumbar vertebra and from the left to the right middle axillary line, In children - Including the lumbar cross | 660 |
| 04.03.042 | Vibration massage of the back and lumbar region (from the VII cervical vertebra to the base of the sacrum and from the left to the right middle axillary line) | 880 |
| 04.03.051 | Vibration massage of the foot and lower leg | 440 |
| 04.03.048 | Vibration massage of the hip joint and gluteal region (the same side) | 880 |
| 04.03.043 | Vibration massage of the cervical spine (the posterior surface of the neck and back to the 1st lumbar vertebra from the left to the right rear axillary | 880 |
| 04.03.027 | Manual therapy (session) | 2 500 |
| 04.03.001 | Massage (Massage unit -1 region 10 I am.) | 660 |
| 04.03.006 | Massage of the upper limb | 880 |
| 04.03.007 | Massage of the upper limb, shoulder streams and spatulas | 1 320 |
| 04.03.005 | Massage of the collar zone | 880 |
| 04.03.025 | Assuming ankle joint | 1 320 |
| 04.03.002 | Head massage | 660 |
| 04.03.011 | Brush massage and forearm | 660 |
| 04.03.024 | The massage of the knee joint | 1 320 |
| 04.03.003 | Facial massage | 660 |
| 04.03.009 | Massage of the elbow joint | 660 |
| 04.03.010 | Wright joint massage | 660 |
| 04.03.014 | Massage of the muscles of the anterior abdominal wall | 660 |
| 04.03.021 | Massage of the lower limb | 880 |
| 04.03.022 | Massage of the lower limb and lower back | 1 320 |
| 04.03.012 | Massage of the chest area | 1 650 |
| 04.03.020 | Massage of the spine | 1 650 |
| 04.03.008 | Massage of the shoulder joint | 660 |
| 04.03.028 | Pneumatic massage (10 minutes) | 550 |
| 04.03.015 | Massage of the lumbosacral region | 660 |
| 04.03.013 | Back massage | 880 |
| 04.03.017 | Back massage and lumbar region | 1 320 |
| 04.03.026 | Massage of the foot and lower leg | 605 |
| 04.03.023 | Massage of the hip joint and gluteal region | 1 320 |
| 04.03.004 | Neck massage | 660 |
| 04.03.018 | Massage of the cervical spine | 1 320 |
| 04.03.044 | Segmental vibration massage of the cervical spine | 1 320 |
| 04.03.041 | Segmental vibration massage of the lumbosacral region | 660 |
| 04.03.016 | Segmental massage of the lumbosacral region | 990 |
| 04.03.019 | Segmental massage of the cervical spine | 1 760 |
| 04.03.029 | Transcarnial magnetic stimulation | 2 200 |
Medical rehabilitation
| The code | Designation | Price |
| 1 | Medical and legal assistance | |
| 04.01.001 | Admission (inspection, consultation) speech therapist | 2 500 |
| 04.01.002 | Repeated reception (inspection, consultation) speech therapist | 1 500 |
| 04.01.003 | A medical and legal study for dysphagia | 650 |
| 04.01.004 | AFASIA of a medical and speech therapy examination | 800 |
| 04.01.005 | Disartria | 650 |
| 04.01.006 | Bedic-speech therapy procedure for dysphagia | 1 000 |
| 04.01.007 | Bedic-speech therapy procedure for aphasia | 1 000 |
| 04.01.008 | Medicopedic procedure for dysarthria | 1 000 |
| 04.01.009 | Bedic-speech therapy tonal-rhythmic procedure | 1 000 |
| 04.01.010 | Bedic-legal procedure using interactive information technologies | 1 000 |
| 2 | Medical-pichological assistance | |
| 04.02.001 | Admission (testing, consultation) medical psychologist, primary | 2 500 |
| 04.02.002 | Admission (testing, consultation) medical psychologist, Repeated | 1 800 |
| 04.02.003 | Clinical and psychological counseling | 1 800 |
| 04.02.004 | Individual clinical and psychological counseling | 1 800 |
| 04.02.005 | Group clinical and psychological counseling | 3 000 |
| 04.02.006 | Family clinical and psychological counseling | 3 000 |
| 04.02.007 | Clinical and psychological correction | 1 800 |
| 04.02.008 | Individual clinical and psychological correction | 1 800 |
| 04.02.009 | Group clinical and psychological correction | 3 000 |
| 04.02.010 | Autogenic training | 2 500 |
| 3 | Medical massage and manual therapy | |
| 04.03.001 | Massage (Massage unit -1 region 10 I am.) | 660 |
| 04.03.002 | Head massage | 660 |
| 04.03.003 | Facial massage | 660 |
| 04.03.004 | Neck massage | 660 |
| 04.03.005 | Massage of the collar zone | 880 |
| 04.03.006 | Massage of the upper limb | 880 |
| 04.03.007 | Massage of the upper limb, shoulder streams and spatulas | 1 320 |
| 04.03.008 | Massage of the shoulder joint | 660 |
| 04.03.009 | Massage of the elbow joint | 660 |
| 04.03.010 | Wright joint massage | 660 |
| 04.03.011 | Brush massage and forearm | 660 |
| 04.03.012 | Massage of the chest area | 1 650 |
| 04.03.013 | Back massage | 880 |
| 04.03.014 | Massage of the muscles of the anterior abdominal wall | 660 |
| 04.03.015 | Massage of the lumbosacral region | 660 |
| 04.03.016 | Segmental massage of the lumbosacral region | 990 |
| 04.03.017 | Back massage and lumbar region | 1 320 |
| 04.03.018 | Massage of the cervical spine | 1 320 |
| 04.03.019 | Segmental massage of the cervical spine | 1 760 |
| 04.03.020 | Massage of the spine | 1 650 |
| 04.03.021 | Massage of the lower limb | 880 |
| 04.03.022 | Massage of the lower limb and lower back | 1 320 |
| 04.03.023 | Massage of the hip joint and gluteal region | 1 320 |
| 04.03.024 | The massage of the knee joint | 1 320 |
| 04.03.025 | Assuming ankle joint | 1 320 |
| 04.03.026 | Massage of the foot and lower leg | 605 |
| 04.03.027 | Manual therapy (session) | 2 500 |
| 04.03.028 | Pneumatic massage (10 minutes) | 550 |
| 04.03.029 | Transcarnial magnetic stimulation | 2 200 |
| 04.03.030 | Vibrational impact (Vibration massage) (Massage unit - 1 region 10 minutes) | 440 |
| 04.03.031 | Vibration massage of the collar zone (The posterior surface of the neck, back to level IV breast vertebra, anterior surface of the chest to II rib) | 660 |
| 04.03.032 | Vibration massage of the upper limb | 660 |
| 04.03.033 | Vibration massage of the upper limb, shoulder streams and spatulas | 880 |
| 04.03.034 | Vibration massage of the shoulder joint (The upper third of the shoulder, areas of the shoulder joint and the shoulder of the side of the same name) | 440 |
| 04.03.035 | Vibration massage of the elbow joint (The upper third of the shoulder, area of the elbow joint and lower third of the shoulder) | 440 |
| 04.03.036 | Vibration massage of the wrist joint (proximal brush, wrist joints and forearms) | 440 |
| 04.03.037 | Vibration massage of the hand and forearm | 440 |
| 04.03.038 | Vibration massage of the chest area (areas of the anterior surface of the chest from the front boundaries of the shoulders to the rib arches and the back of the VII to I lumbar vertebra) | 1 100 |
| 04.03.039 | Vibration back massage (from the VIII cervical to I lumbar vertebra and from the left to the right middle axillary line, In children - Including the lumbosacral region | 660 |
| 04.03.040 | Vibration massage of the lumbosacral region (from I lumbar vertebra to the lower gluteal folds) | 550 |
| 04.03.041 | Segmental vibration massage of the lumbosacral region | 660 |
| 04.03.042 | Vibration massage of the back and lumbar region (from the VII cervical vertebra to the base of the sacrum and from the left to the right middle axillary line) | 880 |
| 04.03.043 | Vibration massage of the cervical spine (rear surface of the neck and back to the 1st lumbar vertebra from the left to the right rear axillary line) | 880 |
| 04.03.044 | Segmental vibration massage of the cervical spine | 1 320 |
| 04.03.045 | Vibration massage of the spine area (The posterior surface of the neck, back and lumbosacral region from the left to the right rear axillary line) | 1 100 |
| 04.03.046 | Vibration massage of the lower limb | 660 |
| 04.03.047 | Vibration massage of the lower limb and lower back (foot areas, shin, hips, gluteal and lumbosacral region) | 880 |
| 04.03.048 | Vibration massage of the hip joint and gluteal region (the same side) | 880 |
| 04.03.049 | Vibration massage of the knee joint (The upper third of the lower leg, the knee joint and lower third of the thigh) | 880 |
| 04.03.050 | Vibration massage of the ankle joint (proximal footing, areas of the ankle joint and lower third of the lower leg) | 880 |
| 04.03.051 | Vibration massage of the foot and lower leg | 440 |
| 4 | Medical physical education | |
| 04.04.001 | Individual lesson of physiotherapy physical education (1 class) | 700 |
| 04.04.002 | Physiotherapy physical education in the group (1 class) | 450 |
| 04.04.003 | Drawing up a plan for the course of physiotherapy exercises | 750 |
| 5 | Mechanotherapy and bio -controlled training (Barefoot) | |
| 04.05.001 | Training with biological feedback on hemodynamic indicators | 440 |
| 04.05.002 | Mechanotherapy on mechanotherapeutic devices with a following drive in diseases of the central nervous system and brain | 550 |
| 04.05.003 | Correction of a violation of the motor function using biological feedback | 440 |
| 04.05.004 | Training with biological feedback on a supporting reaction in diseases of the central nervous system and brain | 550 |
| 04.05.005 | Mechanotherapy for simple mechanotherapeutic devices for diseases of the central nervous system and brain | 660 |
| 04.05.006 | Training with biological feedback on hemodynamic indicators of diseases of the system of hematopoiesis and blood systems | 550 |
| 04.05.007 | BOS therapy (Treatment according to the biological feedback methodology), 1 session | 880 |
| 04.05.008 | Assessment and treatment of the psychological state of the individual (Bos psychological) (30 minutes) | 1 320 |
| 04.05.009 | Assessment and treatment of a speech therapy state of the individual (Bos psychological) (30 minutes) | 1 320 |
| 04.05.010 | Robotized complex (mechano and locomotor therapy) for the rehabilitation of the lower extremities (exoatlet) | 1 650 |
| 04.05.011 | Restoration of fine motor skills and coordination with the assessment of capabilities using BOS (glove) | 770 |
| 04.05.012 | The impact of a high-intensity pulsed magnetic field using biologically feedback by the BTL-6000 Super Inductive System | 770 |
| 04.05.013 | Correction of a violation of the motor function using biological feedback by the simulator Balance Tutor | 990 |
| 04.05.014 | Training with biological feedback on goniographic indicators (on the articular corner) In diseases of the central nervous system and brain, the simulator of the Devort | 880 |
| 04.05.015 | Correction of a motor function using computer technology using the Virtual Reality simulator Devirt | 990 |
| 04.05.016 | Correct functions correction using biologically feedback by the simulator Orthotent Cognitive | 550 |
| 6 | HYDROTHERAPY (BALNEOTHERAPY, Pools) | |
| 04.06.007 | Dry baths from the apparatus "Reabox" | 770 |
| 04.06.010 | Underwater shower-massage therapeutic | 880 |
| 04.06.011 | Individual lesson of physiotherapy exercises in the pool under the guidance of an instructor (1 class) | 660 |
| 04.06.012 | Group lesson of physiotherapy exercises in the pool under the guidance of an instructor (1 class) | 550 |
| 04.06.013 | Individual lesson of physiotherapy exercises in a pool with chloride-nestrian salt under the guidance of an instructor (1 class) | 770 |
| 04.06.014 | Group lesson of physiotherapy exercises in a pool with chloride-nestrian salt under the guidance of an instructor (1 class) | 660 |
| 04.06.015 | Medical swimming in the pool (15 minutes) | 440 |
| 04.06.016 | Medical plug in the pool with chloride-nather (15 minutes) | 550 |
| 04.06.017 | The program of water-thermal therapy | 880 |
| 7 | Empty, Girudotherapy | |
| 04.07.001 | Corporal reflexology (1 session) | 1 000 |
| 04.07.002 | Aurikulophostosis (1 session) | 800 |
| 04.07.003 | Carniopuncture (1 session) | 800 |
| 04.07.005 | Auricodiagnostics (1 session) | 300 |
| 04.07.007 | Branch massage, 1 session | 400 |
| 04.07.008 | Acupuncture with currents of extremely high frequency (ATH Puncture) | 400 |
| 04.07.009 | Superficial reflexology, 1 session | 600 |
| 04.07.010 | Microilotherapy (1 session) | 1 000 |
| 04.07.011 | Pharmacopuncture (1 session) | 800 |
| 04.07.014 | Laseropuncture (1 session) | 600 |
| 8 | Kineseotherapy | |
| 04.08.001 | Kinesiotype facial area | 500 |
| 04.08.002 | Kinesioteperation of the upper extremities (The shoulder shoulder, shoulder joints) | 500 |
| 04.08.003 | Kinesioteperation of the upper extremities (shoulder, forearm) | 500 |
| 04.08.004 | Kinesiotherapy of the hand | 500 |
| 04.08.005 | Kinesioteiing of the cervical spine | 500 |
| 04.08.006 | Kinesioteperation of the thoracic spine | 500 |
| 04.08.007 | Kineseotheraping of the lumbar spine | 500 |
| 04.08.008 | Kineseotherapy of the hip joint | 500 |
| 04.08.009 | Hip kinesiotherapy | 500 |
| 04.08.010 | Kinesioteiing of the knee joint | 500 |
| 04.08.011 | Kineseotherapy of the lower leg, ankle | 500 |
| 04.08.012 | Kinesiotherapy of the foot | 500 |
Procedures
| Administration of drugs intravenously: infusion (dropper) | 300 |
| Intravenous administration of drugs | 200 |
| Intramuscular administration of drugs | 200 |
| Taking blood from a peripheral vein | 200 |
| Taking punctate from the thyroid gland under ultrasound control | 2.500 |
| Taking punctate from the thyroid gland under ultrasound control (each subsequent node) | 600 |
| Registration of medical documentation | 150 |
| Tick removal | 350 |
| Prevention with immunoglobulin against tick-borne encephalitis (1 dose) | 1.500 |
| Spinal puncture | 2.500 |
Physiotherapy
| 1 | ELECTROTHERAPY | |
| 06.01.001 | Galvanization | 330 |
| 06.01.002 | Electrophoresis of drugs | 700 |
| 06.01.003 | Exposure to sinusoidal modulated currents (CMT therapy) | 700 |
| 06.01.004 | Electrophoresis sinusoidal modulated currents (SMT-phoresis) | 750 |
| 06.01.005 | Multifunctional muscle stimulation | 770 |
| 06.01.006 | Exposure to an electric field of ultra -high frequency (EP UHF) | 300 |
| 06.01.007 | Ultrafonophoresis medicinal | 500 |
| 06.01.008 | Ultrasound exposure | 400 |
| 06.01.009 | Exposure to electromagnetic radiation of the decimeter range (DMV) | 400 |
| 06.01.010 | Exposure to short ultraviolet radiation (KUF) | 300 |
| 06.01.011 | Ultraviolet irradiation of the skin | 400 |
| 06.01.012 | Ultraviolet irradiation of the skin. Total narrow -band medium -volume ultraviolet therapy from the apparatus "UV cabin" | 600 |
| 06.01.013 | Darsonvalization | 400 |
| 06.01.014 | Exposure to electromagnetic radiation of the centimeter range (CMV therapy) | 400 |
| 06.01.015 | Exposure to radiation of the visible range | 400 |
| 06.01.016 | Exposure to polarized light | 500 |
| 06.01.018 | electrosleep | 550 |
| 06.01.020 | Exposure to electromagnetic radiation of a millimeter range (EHF therapy) | 500 |
| 06.01.021 | Fluctosorization | 650 |
| 2 | MAGNETOTHERAPY | |
| 06.02.001 | General magnetotherapy | 800 |
| 06.02.002 | Exposure to alternating magnetic field (PeMP) | 600 |
| 06.02.003 | Exposure to running impulse magnetic field | 600 |
| 06.02.004 | Trans regional exposure by magnetic field | 600 |
| 06.02.005 | Magnetophoresis | 650 |
| 3 | WARM- AND OZOKER TREATMENT | |
| 06.03.001 | Infrared radiation is common (infrared sauna, 15 minutes) | 500 |
| 06.03.007 | Compress with cream-balsam "shungite" | 700 |
| 4 | Inhalations and herbal medicine | |
| 06.04.001 | Halotherapy (salt cave) | 550 |
| 06.04.002 | Aerophytotherapy (aromatherapy) | 550 |
| 06.04.003 | Aerosol therapy ( individual inhalation) | 450 |
| 06.04.004 | Phytotherapy (herbal tea) | 350 |
ultrasound
| The code | Designation | Price |
| 07.01.001 | Echocardiography | 2 400 |
| 07.01.003 | Echocardiography | 4 500 |
| 07.01.027 | Stress echocardiography | 5 000 |
| 07.01.004 | Ultrasound study of the kidneys and adrenal glands | 1 500 |
| 07.01.005 | Comprehensive ultrasound examination of internal organs | 2 200 |
| 07.01.006 | Ultrasound examination of the pleural cavity | 1 000 |
| 07.01.007 | Ultrasound liver study, gallbladder, pancreas, spleen | 1 800 |
| 07.01.008 | Ultrasound examination of the thyroid gland and parathyroid glands | 1 500 |
| 07.01.009 | Ultrasound examination of the gallbladder with the determination of its contractility | 1 500 |
| 07.01.010 | Duplex scanning of brachiocephalous arteries with color Doppler mapping of blood flow (neck vessels) | 2 200 |
| 07.01.011 | Ultrasound examination of the pelvic organs (wife) (complex) | 2 300 |
| 07.01.023 | Ultrasound examination of the pelvic organs (wife) (abdominal) | 1 600 |
| 07.01.024 | Ultrasound examination of the pelvic organs (wife) (transvaginal) | 1 800 |
| 07.01.012 | Ultrasound examination of the mammary glands | 1 800 |
| 07.01.013 | Ultrasound examination of the prostate gland transrectal | 2 000 |
| 07.01.014 | Duplex scanning of the arteries of the lower extremities | 2 100 |
| 07.01.015 | Ultrasound dopplerography of the veins of the lower extremities | 2 300 |
| 07.01.016 | Ultrasound dopplerography of the upper limbs | 2 100 |
| 07.01.018 | Ultrasound study of the bladder | 1 200 |
| 07.01.019 | Ultrasound study of soft tissues | 1 400 |
| 07.01.020 | Ultrasound study of the organs of the scrotum | 1 700 |
| 07.01.021 | Duplex scanning of the kidney arteries | 1 900 |
| 07.01.022 | Duplex scanning of the arteries of the upper extremities | 2 100 |
| 07.01.028 | Duplex scanning of transcranial arteries and veins | 2 200 |
| 07.01.029 | Ultrasound joints of the joints (brachial) (pair) | 2 000 |
| 07.01.025 | Ultrasound joints of the joints (brachial) (one) | 1 600 |
| 07.01.026 | Ultrasound study of lymph nodes (one zone) | 1 500 |
Functional diagnostics
| The code | Designation | Price |
| 08.01.001 | Registration of electrocardiograms | 350 |
| 08.01.002 | Decryption, description and interpretation of electrocardiographic data | 500 |
| 08.01.003 | Electrocardiogram (registration with encryption) | 850 |
| 08.01.004 | Bicycle ergometry | 2 000 |
| 08.01.005 | Treadmill test | 2 000 |
| 08.01.006 | Research of respiratory volumes using drugs (Spirography with broncholitics) | 1 500 |
| 08.01.007 | Study of unprovided respiratory volumes and flows (Spirography) | 1 000 |
| 08.01.008 | Electroencephalography | 1 300 |
| 08.01.009 | Daily monitoring of blood pressure | 2 000 |
| 08.01.010 | Holteric monitoring of heart rhythm (XM-ECG) | 2 200 |
| 08.01.011 | Rheoencephalography | 1 000 |
| 08.01.012 | Electromyography is basic (one area) | 1 650 |
Endoscopy
| The code | Designation | Price |
| 09.01.002 | Esophagogastroduodenoscopy | 3 100 |
| 09.01.015 | Esophagogastroscopy interrupted procedure | 1 600 |
| 09.01.003 | Esophagus biopsy using endoscopy | 950 |
| 09.01.004 | Gastric biopsy using endoscopy | 950 |
| 09.01.005 | Duodenal biopsy using endoscopy | 950 |
| 09.01.006 | Endoscopic colon biopsy | 950 |
| 09.01.008 | Sigmoidoscopy | 1 400 |
| 09.01.009 | Colonoscopy | 5 500 |
| 09.01.010 | Sigmoscopy | 2 400 |
| 09.01.013 | Urealed test on Helicobacter pylori | 1 000 |
| 09.01.014 | Scraping from the esophagus mucosa for mycological research | 1 100 |
X -ray
| The code | Designation | Price |
| 10.01.001 | X-ray of the lungs (1 projection) | 950 |
| 10.01.002 | Radiography of the lungs (2 projections) | 1 150 |
| 10.01.003 | Radiography of the lungs (3 projections) | 1 400 |
| 10.01.006 | The radiography of the abdominal cavity (overview) | 1 150 |
| 10.01.008 | X -ray of the first and second cervical vertebra | 825 |
| 10.01.009 | Randiganography of the collarbone | 825 |
| 10.01.010 | X-ray of the sternum-circuit joint | 825 |
| 10.01.011 | X-ray of the acrom-swimming-circuit | 825 |
| 10.01.012 | X -ray of the cervical spine in two projections | 1 150 |
| 10.01.013 | X -ray of the cervical spine (4 projections) | 1 650 |
| 10.01.014 | Radiography of the thoracic spine in two projections | 1 700 |
| 10.01.021 | X -ray of the entire skull, two projections | 1 300 |
| 10.01.022 | Radiography of the sinus of the nose | 950 |
| 10.01.023 | Radiography ribs(er) | 950 |
| 10.01.024 | X -ray of the shoulder joint (1 projection) | 950 |
| 10.01.025 | Radiography of the shoulder joint in two projections | 1 150 |
| 10.01.026 | The radiography of the elbow joint (2 joint in 2 projections) | 1 650 |
| 10.01.027 | Radiography of the elbow joint in two projections (one joint) | 1 150 |
| 10.01.028 | The radiography of the knee joint (2 joint in 2 projections) | 1 650 |
| 10.01.029 | Radiography of the knee joint in two projections | 1 150 |
| 10.01.030 | The radiography of the ankle joint (2 joint in 2 projections) | 1 650 |
| 10.01.031 | Ankle joint radiography in two projections | 1 150 |
| 10.01.032 | X -ray of the heels ( in 1 projections) | 1 150 |
| 10.01.033 | X -ray of the heels in two projections | 950 |
| 10.01.034 | Radiography of the hands in 1 projections | 1 400 |
| 10.01.035 | Randigenography of the brush in two projections | 1 150 |
| 10.01.036 | Stop radiography in one projection | 1 400 |
| 10.01.037 | Foot radiography in two projections | 1 150 |
| 10.01.038 | Foot radiography with a functional load | 1 650 |
| 10.01.039 | X -ray of the femur (2 projections) | 1 150 |
| 10.01.040 | X -ray of the Big Beretsova and Malaya Beretsov (one in 2 projections) | 1 150 |
| 10.01.041 | X -ray of the hip joint (one) in two projections | 1 200 |
| 10.01.042 | X -ray of the hip joints (1projection) | 1 650 |
| 10.01.043 | X -ray of ileosocral joints (1 projection) | 1 200 |
| 10.01.044 | TAZ radiography | 1 650 |
| 10.01.045 | Coscrice radiography | 1 400 |
| 10.01.046 | The X -ray of the sacrum | 1 400 |
| 10.01.047 | X-ray of the lumbosacral spine in two projections | 1 700 |
| 10.01.048 | Radiography of the lumbosacral spine (4 projections) | 2 025 |
Laboratory
| The code | Designation | Price |
| 1 | Studies of general clinical and chemical-microscopic parameters (blood, urine, stay, high humidity) | |
| 11.01.001 | General blood test (OAK) | 450 |
| 11.01.002 | Blood coagulation time | 150 |
| 11.01.003 | Duration of bleeding | 150 |
| 11.01.004 | Examination of the level of reticulocytes in the blood | 250 |
| 11.01.005 | Examination of blood platelets in the blood | 250 |
| 11.01.006 | General urine analysis (OAM) | 240 |
| 11.01.007 | Microscopic examination of urine sediment | 240 |
| 11.01.008 | Study of urine by Nechiporenko | 240 |
| 11.01.009 | Study of urine method by Zimnitsky | 350 |
| 11.01.010 | Three -walled urine test | 500 |
| 11.01.011 | Feces for hidden blood (qualitative) | 250 |
| 11.01.012 | Coprogram | 350 |
| 11.01.013 | Study of feces for helminth eggs and protozoa | 300 |
| 11.01.014 | Study of feces for helminth eggs and the simplest enrichment method | 650 |
| 11.01.015 | Calprotectin, (stay) | 2 200 |
| 11.01.016 | Pancreatic elastasis 1, (stay) | 2 100 |
| 11.01.017 | Carbohydrates in feces (Benedict's trial) | 500 |
| 11.01.018 | Scraping on the enterobiosis | 300 |
| 11.01.019 | General analysis of sputum | 450 |
| 2 | The study of biochemical parameters | |
| 11.02.001 | General protein, (blood) | 185 |
| 11.02.002 | Protein fractions (blood) | 400 |
| 11.02.003 | Albumin, (blood) | 220 |
| 11.02.004 | C-reactive protein (SRB), (blood) | 330 |
| 11.02.005 | Urea, (blood) | 185 |
| 11.02.006 | Creatinine, (blood) | 185 |
| 11.02.007 | Reyraga test (blood and urine) | 250 |
| 11.02.008 | Glomber filtration speed (SKF) per creatinine | 250 |
| 11.02.009 | Uric acid, (blood) | 185 |
| 11.02.010 | Lipid spectrum (blood: TG, total cholesterol , HDL cholesterol, LDL cholesterol, VLDL cholesterol, Atherogenicity coefficient) | 850 |
| 11.02.011 | General cholesterol, (blood) | 200 |
| 11.02.012 | Triglycerides, (blood) | 200 |
| 11.02.013 | Lipoprotein cholesterol (LDL), (blood) | 250 |
| 11.02.014 | Highly lipoprotein cholesterol (HDL), (blood) | 220 |
| 11.02.015 | Apolyprotein A1, (blood) | 500 |
| 11.02.016 | Aopoliprotein c, (blood) | 450 |
| 11.02.017 | Aspartate aminotransferase (IS), (blood) | 185 |
| 11.02.018 | Alanine aminotransferase (GOLD), (blood) | 185 |
| 11.02.019 | Bilirubin is common, (blood) | 185 |
| 11.02.020 | Bilirubin is straight, (blood) | 185 |
| 11.02.021 | Gamma-glutamyl transpeptidase (GGTP), (blood) | 185 |
| 11.02.022 | Lactate dehydrogenase (LDH), (blood) | 185 |
| 11.02.023 | Alkaline phosphatase (Shtf), (blood) | 185 |
| 11.02.024 | Alpha amylase, (blood) | 185 |
| 11.02.025 | Alpha-amylase is pancreatic, (blood) | 300 |
| 11.02.026 | Lipase, (blood) | 350 |
| 11.02.027 | Creatine phosphokinase (KFC), (blood) | 250 |
| 11.02.028 | Creatinephosophkinase MB-fraction (blood; KFC-MV) | 300 |
| 11.02.029 | Angiotensinoproting enzyme (blood; APF) | 2 000 |
| 11.02.030 | Glucose, (blood) | 185 |
| 11.02.031 | Gluczotolerant test (blood; GTT) | 650 |
| 11.02.032 | Glucose (capillary blood) | 150 |
| 11.02.033 | Glichic profile (blood; 2 points) | 300 |
| 11.02.034 | Glycemic profile (blood; 3 points) | 450 |
| 11.02.035 | Glycemic profile (blood; 6 points) | 800 |
| 11.02.036 | Study of blood glucose levels by continuous monitoring | 6 000 |
| 11.02.037 | Lactate (blood) | 550 |
| 11.02.038 | Fructosamine (blood) | 850 |
| 11.02.039 | Glycosylated hemoglobin (blood; HbA1C) | 450 |
| 11.02.040 | Homocysteine | 1 200 |
| 11.02.041 | Albumin (urine) | 450 |
| 11.02.042 | Glucose (urine) | 185 |
| 11.02.043 | Alpha amylase (urine) | 185 |
| 11.02.044 | Albumin's attitude to creatinine (urine) | 450 |
| 11.02.045 | Creatinine (urine) | 185 |
| 11.02.046 | Determining the amount of protein in daily urine (daily urine) | 185 |
| 11.02.047 | Detection of ketone bodies in the urine express method (urine) | 150 |
| 11.02.048 | Lipoprotein a | 550 |
| 3 | Study of hemostasis system indicators (blood) | |
| 11.03.001 | Protrombin Inddenx (PTI) | 185 |
| 11.03.002 | Prothrombin, MANY (prothrombin time) | 250 |
| 11.03.003 | Activated partial thromboplastin time (АХТВ) | 200 |
| 11.03.004 | Thrombin time (TV) | 250 |
| 11.03.005 | D-dimer (quantitatively) | 1 200 |
| 11.03.006 | Plasminogen | 450 |
| 11.03.007 | Protein with | 1 800 |
| 11.03.008 | Fibrinogen | 250 |
| 11.03.009 | Antithrombin III | 450 |
| 11.03.011 | Screening study of the hemostasis system (TV, APTV, MANY, fibrinogen, D-dimer) | 2 000 |
| 11.03.012 | Expanded study of the hemostasis system (TV, APTV, MANY, fibrinogen,D-dimer,Antithrombin III, plasminogen, protein C, lupus anticoagulant) | 4 000 |
| 4 | The study of inorganic substances, ELECTROLYTES, VITAMINS | |
| 11.04.001 | Potassium (blood) | 150 |
| 11.04.002 | Sodium (blood) | 150 |
| 11.04.003 | chlorides (blood) | 150 |
| 11.04.004 | Phosphorus (blood) | 185 |
| 11.04.005 | Magnesium (blood) | 185 |
| 11.04.006 | Calcium is general (roof) | 185 |
| 11.04.007 | Calcium is ionized (blood) | 350 |
| 11.04.008 | Copper (blood) | 1 200 |
| 11.04.009 | 25-He is vitamin D | 1 850 |
| 11.04.010 | Oxalates (daily urine) | 1 500 |
| 11.04.011 | Potassium (urine) | 150 |
| 11.04.012 | Sodium (urine) | 150 |
| 11.04.013 | chlorides (urine) | 150 |
| 11.04.014 | A comprehensive study of iron metabolism (blood; Fe, OHSS, LWSS, saturation factor) | 550 |
| 11.04.015 | Iron (blood) | 185 |
| 11.04.016 | Vitamin v12 (blood) | 650 |
| 11.04.017 | Folic acid (blood) | 650 |
| 11.04.018 | Zinc (blood) | 600 |
| 5 | The study of hormones | |
| 11.05.001 | Thyrotropic hormone (The CIA) | 350 |
| 11.05.002 | Triidotyrine is common (T3) | 350 |
| 11.05.003 | Triidotyrine is free (T3st) | 350 |
| 11.05.004 | Troxine is general (T4) | 350 |
| 11.05.005 | Troxine is free (T4 St) | 350 |
| 11.05.006 | Prolactin | 425 |
| 11.05.007 | C-peptide (blood) | 495 |
| 11.05.008 | Insulin (blood) | 580 |
| 11.05.009 | Proinsulin (blood) | 750 |
| 11.05.010 | Erythropoietin | 1 000 |
| 11.05.011 | Luteinizing hormone (LG) | 425 |
| 11.05.012 | Follicle -stimulating hormone (FSH) | 425 |
| 11.05.013 | Estradiol | 425 |
| 11.05.014 | The estradiol is free | 550 |
| 11.05.015 | Progesterone | 425 |
| 11.05.016 | Testosterone is common | 425 |
| 11.05.017 | Testosterone is free | 1 000 |
| 11.05.018 | Dihydrotestosterone (DHT) | 1 250 |
| 11.05.019 | Dehidroepandrosterone sulfate (DGEA) | 425 |
| 11.05.020 | 17-hydroxyprogesterone (blood; 17-OKS) | 580 |
| 11.05.021 | Cortisol (urine) | 650 |
| 11.05.022 | Cortisol (blood) | 485 |
| 11.05.023 | Somatotropic hormone (STG) | 550 |
| 11.05.024 | Insulin -like growth factor I (IFR) | 1 200 |
| 11.05.025 | Antimuller hormone (AMG) | 1 200 |
| 11.05.026 | Paratyroid hormone | 750 |
| 11.05.027 | Adrenocorticotropic hormone (ACTH) | 750 |
| 11.05.028 | Nephrines: methenephrine, normetanephrine, (blood) | 2 000 |
| 11.05.029 | Catecholamine (adrenaline, norepinephrine, dopamine) | 2 500 |
| 11.05.030 | Aldosterone | 550 |
| 11.05.031 | Androstenedione | 1 100 |
| 11.05.032 | Renin | 750 |
| 11.05.033 | Aldosterone-Renin ratio (Aldosterone-Renin Ratio, ARR) | 1 350 |
| 11.05.034 | Pepsinogen i | 550 |
| 11.05.035 | Pepsinogen II | 550 |
| 11.05.036 | Gastrin | 650 |
| 11.05.037 | Catecholamine (adrenaline, norepinephrine, dopamine; urine) | 2 950 |
| 11.05.038 | 17-hydrocorticosteroid, (17-OKS; urine) | 2 500 |
| 11.05.039 | Free cortisol (daily urine) | 680 |
| 11.05.040 | Nephrines: methenephrine, normetanephrine (daily urine) | 2 000 |
| 11.05.041 | Beta-chorionic gonadotropin (hCG) | 425 |
| 6 | Research of anemia markers | |
| 11.04.015 | Iron (blood) | 185 |
| 11.06.016 | Total iron -binding capacity of serum (OHSS) | 185 |
| 11.06.017 | Latent iron -binding capacity of serum (LWSS) | 250 |
| 11.04.014 | A comprehensive study of iron metabolism (blood; Fe, OHSS, LWSS, saturation factor) | 550 |
| 11.04.016 | Vitamin v12 (blood) | 650 |
| 11.04.017 | Folic acid (blood) | 650 |
| 11.05.010 | Erythropoietin | 1 000 |
| 7 | Research on cancer markers and specific proteins | |
| 11.07.001 | Cancer embryonic antigen (REA) | 600 |
| 11.07.002 | Alpha fetoprotein | 425 |
| 11.07.003 | Prostates -specific antigen is common (PSA) | 520 |
| 11.07.004 | Prostatespecific antigen is free (PSA free) | 520 |
| 11.07.006 | CA 19-9 (Carbohydrate antigen CA 19-9) | 680 |
| 11.07.007 | CA-125 (Cancer antigen 125) | 620 |
| 11.07.008 | THAT 15.3 (Cancer antigen 15-3) | 680 |
| 11.07.009 | CA-242 (Carbohydrate antigen CA-242) | 750 |
| 11.07.010 | A comprehensive examination of ovarian cancer (NO4, SA125, index ROMA1; ROMA2 index) | 1 900 |
| 11.07.011 | WITH 72-4 (Carbohydrate antigen 72-4) | 800 |
| 11.07.012 | Soluble fragment of cytocuratin 19 (DIGIT 21.1) | 850 |
| 11.07.013 | Neuronspecific Enolase. (NSE) | 1 200 |
| 11.07.014 | S-100 protein | 2 100 |
| 11.07.015 | Antigen of flat cell carcinoma (SCC) | 2 100 |
| 11.07.016 | UBS (bladder cancer marker) (urine) | 1 900 |
| 11.07.017 | Trophisticated glycoprotein (TBG) | 450 |
| 11.05.041 | Beta-chorionic gonadotropin (hCG) | 425 |
| 11.07.018 | Prenatal screening 2 trimester: AFP, hCG, NE (PRISCUS II) | 1 700 |
| 11.07.019 | HE4 (Protein 4 human epididymis) | 1 000 |
| 11.07.020 | Troponin T high -quality, (blood) | 650 |
| 11.07.021 | Antistreptolysin-O (ABSOLUTELY), (blood) | 450 |
| 11.07.022 | Cerulloplasmin, (blood) | 650 |
| 11.07.023 | Beta-2 microglobulin, (blood) | 750 |
| 11.07.024 | Protein of Bens-Jones (urine) | 2 500 |
| 11.07.025 | myoglobin, (blood) | 650 |
| 11.07.026 | N-thermal fragment of the sodium-re-propeptate of the cerebral (NT-proBNP), (blood) | 2 500 |
| 11.07.027 | Osteocalcin | 750 |
| 11.07.028 | Procalcitonin | 1 750 |
| 11.07.029 | Calcitonin | 850 |
| 11.07.030 | Transferrin (blood) | 450 |
| 11.07.031 | Ferritin (blood) | 550 |
| 11.07.032 | Neopterin | 1 500 |
| 11.07.033 | Troponin I quantitative, (blood) | 650 |
| 11.07.034 | Chrombranin a | 4 000 |
| 8 | Research microscopic and cytological | |
| 11.08.004 | Microscopic examination of a native and painted drug sputum | 550 |
| 11.08.005 | Cytological examination of sputum | 650 |
| 11.08.007 | Cytological examination of the micropunctic of the thyroid gland | 750 |
| 11.08.008 | Cytological study of scrapings from the cervix and cervical canal | 550 |
| 11.08.009 | Study of duodenal contents microscopic | 2 000 |
| 11.08.010 | Minuted study of duodenal contents with a conclusion | 2 000 |
| 11.08.011 | Duodenal sounding (with flushing) | 2 500 |
| 11.08.012 | Cytological study of punctures, scrapings | 650 |
| 11.08.013 | Microscopic examination of prostate secret sedimentation | 650 |
| 11.08.014 | Scrap microscopy from the skin | 650 |
| 11.08.015 | Microscopic examination of lavage fluid on atypical cells | 650 |
| 11.08.016 | Microscopic examination of lavage fluid on VK | 650 |
| 11.08.017 | Rhinocytogram | 650 |
| 11.08.018 | Microbiological examination of smear from genitourinary organs (urethra, vagina, Cervical Canal) | 350 |
| 9 | Studies of clinical and microbiological, CULTURAL (bacterial crops) | |
| 11.09.001 | Bacteriological examination of mucus from tonsils and the posterior wall of the pharynx for aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.002 | Bacteriological examination of flushing from the perinosos cavities on aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.003 | Bacteriological examination of flushing from the perinosos cavities to golden staphylococci cavities (Staphylococcus aureus) | 350 |
| 11.09.004 | Bacteriological examination of mucus from tonsils and the posterior wall of the pharynx for golden staphylococci (Staphylococcus aureus) | 350 |
| 11.09.005 | Mycological study of nasopharyngeal flushing on mushrooms (Candida spp.) | 300 |
| 11.09.006 | Mycological study of the scraping of the oral cavity for mushrooms of the genus (Candida spp.) | 450 |
| 11.09.007 | Bacteriological examination of the separated from the ears to aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.008 | Mycological study of the family of mushrooms of the genus Candidate (Candidа spp.) | 450 |
| 11.09.009 | Bacteriological examination of sputum for aerobic and optional-anaerobic microorganisms | 800 |
| 11.09.010 | Bacteriological examination of lavage fluid for aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.011 | Bacteriological examination of the separated urethra for aerobic and optional-anaerobic conditionally pathogenic microorganisms | 650 |
| 11.09.012 | Bacteriological study of the separated secret of the prostate for aerobic and optional-anaerobic conditionally pathogenic microorganisms | 650 |
| 11.09.013 | Bacteriological examination of the separated female genital organs on aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.014 | Mycological study of the separated female genitals for mushrooms of the genus (CandidAspp.) | 450 |
| 11.09.015 | Bacteriological examination of sperm for aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.016 | Bacteriological examination of the aspirate of the uterine cavity for aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.017 | The study of intestinal microbiocenosis (dysbacteriosis) | 1 250 |
| 11.09.018 | Cultural research on the dysenteria group, salmonella | 450 |
| 11.09.019 | Bacteriological examination of feces for golden staphylococci (Staphylococcus aureus) | 350 |
| 11.09.020 | Bacteriological examination of feces for conditionally pathogenic microflora | 550 |
| 11.09.021 | Bacteriological examination of aspiration aspirate | 800 |
| 11.09.022 | Mycological study of feces for mushrooms of the genus Candidate (Candida spp.) | 450 |
| 11.09.023 | Immunochromatographic express test for the detection of toxins A and B Clostridium difficile in feces | 1 200 |
| 11.09.024 | Bacteriological blood test for sterility | 950 |
| 11.09.025 | Bacteriological examination of the blood for a typhoid-paratyphone group of microorganisms | 450 |
| 11.09.026 | Bacteriological examination of the separated conjunctiva (tear fluid) on aerobic and optional-anaerobic conditionally pathogenic microorganisms | 650 |
| 11.09.027 | Microbiological examination of urine for aerobic and optional-anaerobic conditionally pathogenic microorganisms | 650 |
| 11.09.028 | Study for yeast -like mushrooms (Candida spp.) cultural method | 450 |
| 11.09.029 | Determining the sensitivity of microorganisms to antibiotics and other drugs | 550 |
| 11.09.030 | Bacteriological examination of the wound separated to aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.031 | Bacteriological examination of the purulent departure to aerobic and optional-anaerobic microorganisms | 650 |
| 11.09.032 | Microbiological examination of smear from the skin | 650 |
| 11.09.033 | Mycological study of scraping from skin to mushrooms of the genus Candidate (Candida spp.) | 450 |
| 11.09.034 | Bacteriological examination of bile for aerobic and optional-anaerobic microorganisms | 450 |
| 11.09.035 | Microbiological examination of breast milk on microflora | 650 |
| 11.09.037 | Microbiological examination of the spinal fluid on aerobic and optional-anaerobic microorganisms | 650 |
| 10 | Study of serological markers of infections | |
| 11.10.001 | HBsAg, qualitative test (HBs-antigen, hepatitis B surface antigen) | 350 |
| 11.10.002 | Total antibodies to the hepatitis C virus (anti-HCV total) | 350 |
| 11.10.003 | Late antibodies with Core---the hepatitis B virus (Anti-HBc IgG) | 500 |
| 11.10.004 | Early antibodies with Core---the hepatitis B virus (Anti-HBc IgМ) | 650 |
| 11.10.005 | Antibodies to HBS antigen hepatitis B virus (Anti-Hbs) | 550 |
| 11.10.006 | Antibodies to Hb-antigen hepatitis B virus (Anti-HBE) | 500 |
| 11.10.007 | Ranie Antibodies (IgM) to the hepatitis C virus (Anti-HCV-IgM) | 550 |
| 11.10.008 | Hepatitis a, early IgM antibodies (Anti-HAV-IgM) | 850 |
| 11.10.009 | Late antibodies IgG hepatitis a (Anti-HAV-IgG) | 750 |
| 11.10.010 | late antibodies (IgG) hepatitis E virus (Anti-HEV-IgG) | 750 |
| 11.10.011 | Total antibodies to the hepatitis D virus (Аnti-HDV total) | 550 |
| 11.10.012 | Early antibodies to the hepatitis D virus (Аnti-HDV IgM) | 800 |
| 11.10.013 | RPR test for the identification of TrePONEMA PALLIDUM (anticardiolipin test) | 350 |
| 11.10.014 | Total antibodies to TrePONEMA PALLIDUM (IgG, IgM) | 400 |
| 11.10.015 | Late antibodies to Treponema Pallidum (IgG) | 400 |
| 11.10.016 | Early antibodies to Treponema Pallidum (IgM) | 750 |
| 11.10.017 | Determination of IGM antibodies to coronavirus infection SARS-CO-V-2 using ELISA (Blood test) | 950 |
| 11.10.018 | Determination of IGG antibodies to coronavirus infection SARS-CO-V-2 using ELISA (blood analysis) | 950 |
| 11.10.019 | Determination of IGM and IgG antibodies to the coronavirus infection of SARS-CO-V-2 using ELISA (blood analysis) | 1 750 |
| 11.10.020 | Antibodies to HIV 1 and 2 and HIV antigen 1 | 350 |
| 11.10.021 | Secretory antibodies (IgA) к Chlamidia pneumoniae | 600 |
| 11.10.022 | Antibodies (IgМ/IgG) к Mycoplasma pneumoniae | 950 |
| 11.10.023 | late antibodies (IgG) к Mycoplasma hominis | 650 |
| 11.10.024 | Secretory antibodies (IgA) к Toxoplasma gondii | 650 |
| 11.10.025 | IgM and IgG classes antibodies; determination of IgG avidity to Toxoplasma gondii | 1 350 |
| 11.10.026 | late antibodies (IgG) to herpes simplex virus 1 and 2 types | 500 |
| 11.10.027 | Ranie Antibodies (IgM) to herpes simplex virus 1 and 2 types | 500 |
| 11.10.028 | IgM and IgG classes antibodies; determination of IgG avidity to herpes simplex virus 1 and 2 types | 1 350 |
| 11.10.029 | late antibodies (IgG) to human herpesvirus type 8 | 750 |
| 11.10.030 | late antibodies (IgG) to human herpesvirus type 6 | 750 |
| 11.10.031 | late antibodies (IgG) k cytomegalovirus (Cytomegalovirus) | 450 |
| 11.10.032 | Ranie Antibodies (IgM) k cytomegalovirus (Cytomegalovirus) | 550 |
| 11.10.033 | IgM and IgG classes antibodies; determination of IgG avidity to cytomegalovirus (Cytomegalovirus) | 1 350 |
| 11.10.034 | late antibodies (IgG) to the rubella virus (Rubella virus) | 500 |
| 11.10.035 | Ranie Antibodies (IgM) to the rubella virus (Rubella virus) | 500 |
| 11.10.036 | IgM and IgG classes antibodies; determination of IgG avidity to rubella virus (Rubella virus) | 1 350 |
| 11.10.037 | Torch IGG/IgM Torch/IGM., avidity | 3 950 |
| 11.10.038 | late antibodies (IgG) to Helicobacter (Helicobacter pylori) | 550 |
| 11.10.039 | Secretory antibodies (IgA) to Helicobacter (Helicobacter pylori) | 650 |
| 11.10.040 | Ranie Antibodies (IgM) to Helicobacter (Helicobacter pylori) | 650 |
| 11.10.041 | Antigen Helicobquetr Pilory (Helicobacter pylori) in feces | 800 |
| 11.10.042 | IgM antibodies to the tick -borne encephalitis virus | 550 |
| 11.10.043 | IgG antibodies to the tick -borne encephalitis virus | 550 |
| 11.10.044 | Ranie Antitel (IgM) To the pathogens of ixodod tick -borne borreliosis of the Borrelia Burgdorferferi group | 550 |
| 11.10.045 | Late antibodies (IgG to the pathogens of ixodod tick -borne borreliosis of the Borrelia Burgdorferi group | 550 |
| 11.10.046 | Infect mononuction of mononuction VCA- IgM | 550 |
| 11.10.047 | Infect mononuction mononuction of ea-igg (to the early antigen) | 550 |
| 11.10.048 | Infect mononuction of mononuction na-igg | 550 |
| 11.10.049 | Infect mononuction of mononuction VCA- IgG | 550 |
| 11.10.050 | late antibodies (IgG) to toxocar antigens | 650 |
| 11.10.051 | late antibodies (IgG) to the varicella-zoster virus and herpes zoster (Varicella-Zoster virus | 700 |
| 11.10.052 | Ranie Antibodies (IgM) to the varicella-zoster virus and herpes zoster (Varicella-Zoster virus) | 750 |
| 11.10.053 | Ranie Antibodies (IgM) к Bortedella pertussis (whooping cough) | 790 |
| 11.10.054 | Secretory antibodies (IgA) к Bortedella pertussis (whooping cough) | 850 |
| 11.10.055 | late antibodies (IgG) к Bortedella pertussis (whooping cough) | 850 |
| 11.10.056 | Ranie Antibodies (IgM) to the measles virus | 700 |
| 11.10.057 | late antibodies (IgG) to the measles virus | 750 |
| 11.10.058 | RPGA with rash diagnosticum | 450 |
| 11.10.059 | Secretory antibodies (IgA) кYersinia Enterocolitica | 550 |
| 11.10.060 | late antibodies (IgG) кYersinia Enterocolitica | 550 |
| 11.10.061 | Antibodies to Salmonella Typhi (typhoid fever) (RPG) | 550 |
| 11.10.062 | Complex study of AT to helminths:opisthorchiasis, Echinococcosis, toxocarosis, trichinellosis | 2 000 |
| 11.10.063 | Total antibodies to Lamblia Intestinalis (IgA, IgG, IgM) | 750 |
| 11.10.064 | late antibodies (IgG) к Opistorchis Felineus (opisthorchiasis) | 750 |
| 11.10.065 | IGM antibodies, IgG and CEC to opisthorchis antigens | 750 |
| 11.10.066 | IgG class antibodies to Trichinell antigens (anti-Trichinella IgG) | 750 |
| 11.10.067 | Anti-Echinococcus-IgG (IgG class antibodies to echinococcus antigens) | 750 |
| 11 | Research of infections by PCR | |
| 11.11.001 | DNA of hepatitis in virus in (Hepatitis B virus) quantitative research | 3 200 |
| 11.11.002 | RNA of hepatitis C virus (Hepatitis C virus) quantitative research | 3 200 |
| 11.11.003 | DNA of hepatitis in virus in (Hepatitis B virus) qualitative research | 450 |
| 11.11.004 | RNA of hepatitis C virus (Hepatitis C virus) qualitative research | 750 |
| 11.11.005 | Determination of the genotype of the hepatitis C virus (Hepatitis C virus) | 900 |
| 11.11.006 | RNA of hepatitis D virus (Hepatitis D virus) qualitative research | 750 |
| 11.11.007 | RNA Hepatitis G virus | 750 |
| 11.11.008 | DNA of chlamydia Trachomatis (Chlamidia trachomatis) | 350 |
| 11.11.009 | DNA ureapaplasma urealitics (Ureaplasma urealyticum) | 350 |
| 11.11.010 | DNA ureaplasma Parvum (Ureaplasma minor) | 350 |
| 11.11.011 | Днк ur.urealiticum и ur.parvum | 650 |
| 11.11.012 | DNA of mycoplasma Hominis (Mycoplasma of man) | 350 |
| 11.11.013 | DNA mycoplasma genitalium (Mycoplasma genitalia) | 350 |
| 11.11.014 | DNA Trichomones (Trichonomas vaginalis) | 350 |
| 11.11.015 | DNA Gardnerella (Gardnerella vaginalis) | 350 |
| 11.11.016 | Dnk Gonokocc (N. Gonorrhoeae) | 350 |
| 11.11.017 | DNA candidate (Candida albicans) | 350 |
| 11.11.018 | DNA treponema (Treponema pale) | 350 |
| 11.11.019 | DNA mycoplasma (Micoplasma pneumoniae) | 450 |
| 11.11.020 | Testing for the identification of a new coronavirus infection (COVID-19)- PCR method (excluding the fence of the material) | 1 750 |
| 11.11.021 | Testing for the identification of a new coronavirus infection (COVID-19)- PCR method (Taking into account the fence of the material) | 1 900 |
| 11.11.024 | DNA of the windplane virus (Varicella Zoster Virus) | 550 |
| 11.11.025 | DNA virus simplex herpes 1,2 type (HSV-1,2) | 550 |
| 11.11.026 | DNA virus simplex herpes 6 (Herpes simplex virus 6) | 350 |
| 11.11.027 | DNA virus simplex herpes 8 (Herpes simplex virus 8) | 350 |
| 11.11.028 | DNA virus Epstein-barra (EBV) | 350 |
| 11.11.029 | DNA virus Epstein-barra (EBV) quantitation | 550 |
| 11.11.030 | DNA of human papilloma virus HPV-16.18 High-quality | 550 |
| 11.11.031 | DNA of human papilloma virus HPV-6,11 | 550 |
| 11.11.032 | DNA virus papilloma Human HPV-31.33 Type | 550 |
| 11.11.033 | DNA virus of human papilloma HPV-high carcinogenic risk (16,18,31,33,35,39,44,45,51,52,56,58,59 types) | 1 250 |
| 11.11.034 | DNA HPV 21 type (6, 11, 16, 18, 26, 31, 33, 35, 39, 44, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) | 2 950 |
| 11.11.035 | DNA toxoplasmosis (Toxoplasma gondii) | 350 |
| 11.11.036 | RNA virus rubella (for.Rubella ) | 650 |
| 11.11.037 | DNA cytomegalovirus (SMV) qualitative | 450 |
| 11.11.038 | DNA cytomegalovirus (SMV) quantitative | 450 |
| 11.11.039 | RNA virus tick -borne encephalitis | 550 |
| 11.11.040 | DNA Borrelia Burgdorferi | 550 |
| 11.11.041 | RNA virus of tick -borne encephalitis and DNA Borrelia Burgdorferi | 850 |
| 11.11.042 | Blood tick -borne encephalitis antigen | 550 |
| 11.11.043 | ДНК Rickettsia species | 550 |
| 11.11.044 | A complex study of the tick (РНК Tick-borne encephalitis Virus, DNA Borrelia Burgdorferi S.L., Anaplasma, Ehrlichia) with differentiation | 1 500 |
| 11.11.045 | ДНК Anaplasma phagocytophilum, Ehrlichia muris, Ehrlichia chaffeensis | 750 |
| 11.11.046 | DNA Babesia Species (mite) | 550 |
| 11.11.047 | Qualitative RNA definition (Influenza virus A/B) PCR method | 750 |
| 11.11.048 | PCR Screening 15 the most common pathogens of epidemic and seasonal acute respiratory viral infections of human (SARS) | 2 950 |
| 12 | Study of immune status parameters | |
| 11.12.001 | Immunoglobulin A, IgA | 300 |
| 11.12.002 | Immunoglobulin g, IgG | 300 |
| 11.12.003 | Immunoglobulin m, IgM | 300 |
| 11.12.004 | Immunoglobulin E, IgE | 550 |
| 14 | Study of antibodies to antigens of tissues and secrets (autoimmune diseases) | |
| 11.14.001 | Rheumatoid factor (RF), (blood) | 400 |
| 11.14.002 | The lupus antkoagulant (THE) | 850 |
| 11.14.003 | Citrollinized Vimenin (Sa-antigen), IgG antibodies) | 1 350 |
| 11.14.004 | Antibodies to cyclical citrollin -containing peptide (anti-ССP) | 1 350 |
| 11.14.005 | Antisperal antibodies | 950 |
| 11.14.006 | Antibodies to smooth muscles (ASMA) | 1 350 |
| 11.14.007 | Antibodies to thyreoperoxidase (AT-TPO) | 450 |
| 11.14.008 | Antibodies to thyroidoglobulin (AT-TG) | 485 |
| 11.14.009 | Antibodies to the microsomal fraction of thyroidocytes | 550 |
| 11.14.010 | Thyroglobulin (TG) | 600 |
| 11.14.011 | Thyroxine-binding globulin (TSG) | 550 |
| 11.14.012 | Antibodies to the TSH receptor | 1 350 |
| 11.14.013 | Globulin, sex hormone binding (GSPG) | 485 |
| 11.14.014 | Antibodies to heart muscles | 1 350 |
| 11.14.015 | Antibodies to liver and kidney microsomes (LKM-1) | 1 350 |
| 11.14.016 | Antibodies to cardiolipin total (qualitative) | 1 150 |
| 11.14.017 | Antibodies to Cardiolipin (IgG) | 750 |
| 11.14.018 | Antibodies to Cardiolipin (IgM) | 950 |
| 11.14.019 | Antibodies to the cytoplasm of neutrophils (ANCA) | 1 850 |
| 11.14.020 | Antimitochondrial antibodies (BUT) | 1 550 |
| 11.14.021 | Class G antibodies to double (native) DNA / anti-dsDNA | 650 |
| 11.14.022 | Antibodies to platelets | 1 250 |
| 11.14.023 | Anti -core antibodies / Antinuclear antibodies (ANAs, EIA) | 650 |
| 11.14.024 | Spectrum of antinuclear antibodies (Sm, Sm/RNP, SSA SSB Jo-1, CENP-B, ScL-70) | 3 800 |
| 11.14.025 | ANA profile (16 indicators: nRNP/Sm, Sm, RNP 70 -A -C, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, dsDNA, Nucleosomes, Histone, Rib. P-Protein, AMA-M2, BlotAnalysis) | 3 500 |
| 11.14.026 | Myosite profile (7 indicators: Mi-2, To, Pm-Scl, Jo-1, PL-7, PL-12,Ro-52, BlotAnalysis) | 3 700 |
| 11.14.027 | Autoimmune liver diseases (9 indicators: AMA-M2, M2-3E (BPO), Sp100, PML, gp210, LKM-1, LC-1, SLA/LP,Ro-52, BlotAnalysis) | 3 550 |
| 11.14.028 | Antiperinuclear factor (APF) | 1 250 |
| 11.14.029 | Antibodies to insulin (blood) | 650 |
| 11.14.030 | Antibodies to pancreatic beta-cells (blood) | 1 350 |
| 11.14.031 | Antibodies K Glutamatecardearboxylase (blood; Anti-GAD IgG) | 1 550 |
| 11.14.032 | β-2-glycoproteid I, IgG antibodies | 1 350 |
| 11.14.033 | β-2-glycoproteid I, IgM antibodies | 1 350 |
| 11.14.034 | Annexin V, IgG antibodies, (apoptosis marker) | 1 250 |
| 11.14.035 | Annexin V, IgM antibodies | 1 250 |
| 15 | Studies of blood cell antigens and alloimmune anti -erro -cytic antibodies | |
| 11.15.001 | Blood group ((A, AT, 0) | 300 |
| 11.15.002 | Rh factor (Rh) | 300 |
| 11.15.003 | Rh (C, E, c, e), Kell - phenotyping (Rh C, E, c, e, Kell phenotyping) | 750 |
| 11.15.004 | ALLOMMUMUNION ANTILES (including antibodies to Rh antigen) | 550 |
| 18 | Research molecular genetic (oncogenetics, hereditary diseases) | |
| 11.18.001 | Class HLA II General Genes (DRB1, DQA1, DQB1) | 4 500 |
| 11.18.002 | Bekhterev disease (HLA-B27) | 2 500 |
| 11.18.003 | Hereditary hyperbilirubinemia (Gilbert's syndrome) UGT1A1 | 4 000 |
| 11.18.012 | View a histological drug | 1 250 |
| 11.18.013 | Remote description and interpretation of histological micropreparations using telemedicine technologies | 2 500 |
| 11.18.014 | Pathological and anatomical study of biopsy (operational) material of the first category of complexity | 1 250 |
| 11.18.015 | Pathological and anatomical study of biopsy (operational) material of the second category of complexity | 1 500 |
| 11.18.016 | Pathological and anatomical study of biopsy (operational) material of the third category of complexity | 1 750 |
| 11.18.017 | Pathological and anatomical study of biopsy (operational) the fourth category of complexity | 2 500 |
| 11.18.018 | Pathological and anatomical study of biopsy (operational) material of the fifth category of complexity | 3 500 |
| 11.18.019 | Molecular genetic study of mutations in the BRCA1 and BRCA2 genes in the blood | 5 500 |
| 11.18.020 | Molecular genetic study of mutations in the CHEK2 gene in the blood method | 3 500 |
| 11.18.021 | Molecular genetic study of mutations in the EGFR gene in the blood method by PCR | 12 000 |
| 11.18.022 | Molecular genetic study of mutations in the KRAS gene with vibiopsy (operational) material | 8 000 |
| 11.18.023 | Molecular genetic study of mutations in the NRAS gene in biopsy (operational) material | 8 000 |
| 11.18.024 | Molecular genetic study of mutations in the BRAF gene in biopsy (operational) material | 8 000 |
| 11.18.025 | Molecular genetic study of mutations in the BRCA1 gene in biopsy (operational) material | 8 000 |
| 11.18.026 | Molecular genetic study of mutations in the BRCA2 gene in biopsy (operational) material | 3 500 |
| 11.18.027 | Molecular genetic study of mutations in the C-kit gene in biopsy (operational) material | 12 000 |
| 11.18.028 | Molecular genetic study of mutations in the EGFR gene in biopsy (operational) material | 18 000 |
| 11.18.029 | Molecular genetic study of translocations Alk gene | 12 000 |
| 11.18.030 | Molecular genetic study of translocations of the ROS1 gene | 12 000 |
| 11.18.031 | Determination of microsatellite instability in biopsy (operational) material by PCR | 10 000 |
| 11.18.032 | Molecular genetic study of mutations in the BRCA gene in biopsy (operational) material by NGS | 37 000 |
| 11.18.033 | Determination of protein expression PDL1 (SP263) immunohistochemical method | 19 000 |
| 11.18.034 | Determination of protein expression PDL1 (22C3) immunohistochemical method | 17 000 |
| 11.18.035 | Determination of protein expression PDL1 (SP142) immunohistochemical method | 19 000 |
| 11.18.036 | Determination of protein expression PDL1 (28-8) immunohistochemical method | 15 000 |
| 11.18.037 | Pathological and anatomical examination of the protein to the Her2/Neu receptors with a simbing of immunohistochemical methods | 6 500 |
| 11.18.038 | Molecular genetic study of mutations in the Pik3CA gene | 12 000 |
| 11.18.039 | Molecular genetic study of mutations in the Her2/Neu gene (overexpression) | 10 000 |
| 11.18.040 | Molecular genetic study with colorectal cancer (BRAF, KRAS, NRAS) (qualitative) | 17 000 |
| 11.18.041 | Molecular genetic study of mutation in the V617F gene (replacement of the 617th amino acid from valin to phenylalanine) JAK2 (Janus Tyrosin-Kinaz of the second type | 5 000 |
| 11.18.042 | Molecular genetic study with thyroid cancer (exons 10,11,13,14, 15 Ret gene) | 15 000 |
| 11.18.043 | Molecular genetic study of pH-non-neigative myelopoliflative diseases (mutations in gene Calr) | 7 500 |
| 11.18.044 | Immunogymic diagnosis of stomach cancer (Antibodies KI-67, Her2/or) | 5 500 |
| 11.18.045 | Immunogymic diagnosis of receptor status of breast cancer (antibodies er, PR, Ki-67, Her2/or) | 12 000 |
| 11.18.046 | Immunohistochemical study of endometrial receptive: IS, PR | 6 000 |
| 11.18.047 | Immunogymic study (IGH) With antibodies ER | 3 000 |
| 11.18.048 | Immunogymic study (IGH) With antibodies PR | 3 000 |
| 11.18.049 | Immunogymic study (IGH) With antibodies Ki-67 | 3 000 |
| 11.18.050 | Determination of translocation 1P/19Q (qualitative) (FISH) | 17 000 |
| 11.18.051 | Molecular genetic study of mutation in the IDH1 gene (qualitative) | 12 000 |
| 11.18.052 | Molecular genetic study of mutation in the IDH2 gene (qualitative) | 12 000 |
| 11.18.053 | Molecular genetic study of mutations in gene ntrk1, Ntrk2, Ntrk3 by FISH | 45 000 |
| 11.18.054 | Molecular genetic study of mutations in the PDGFRA gene | 25 000 |
| 11.18.055 | Determination of amplification of the ERBB2 gene (Her2/or) In biopsy (operational) material by fluorescent hybridization in situ (FISH) | 15 000 |
| 11.18.056 | Immunogymic study (1 IGH ALK reaction) | 12 000 |
| 11.18.058 | Determination of translocations of the EWSR1 gene (FISH) | 17 000 |
| 11.18.059 | Determination of the expression of the BCR-BLP210 MRNK (quantitative) | 7 500 |
| 11.18.060 | Determination of the expression of the BCR-BLP190 MRNK (quantitative) | 7 500 |
| 11.18.061 | Molecular genetic study(9;22) p210, p190, p230 | 8 500 |
| 11.18.062 | Cytogenetic study (karyotype) bone marrow | 15 000 |
| 11.18.063 | Molecular genetic study in the NTRK gene by NGS | 30 000 |
| 11.18.065 | Molecular genetic study with non-alcoholic cancer of the lung method of NGS sequencing (EGFR, BRAF, KRAS, MET, ERBB1 (Her), ALK, ROS, NTRK | 60 000 |
| 11.18.066 | Pathological and anatomical study of biopsy (operational) material using immunohistochemical methods (1-3 antibodies) | 8 000 |
| 11.18.067 | Pathological and anatomical study of biopsy (operational) material using immunohistochemical methods (4-5 antibodies) | 12 000 |
| 11.18.068 | Pathological and anatomical study of biopsy (operational) material using immunohistochemical methods (6-8 antibodies) | 18 000 |
| 11.18.069 | Pathological and anatomical study of biopsy (operational) material using immunohistochemical methods (more 8 antibodies) | 25 000 |
| 11.18.070 | Analysis of mutations in the MPL gene, PCR, qualitative | 3 500 |
| 11.18.071 | Determination of the amplification of the C-MYC gene in biopsy (operational) material by fluorescent hybridization in situ (FISH) | 20 000 |
| 11.18.072 | Determination of translocation of the BCL2 gene by fluorescent hybridization in situ (FISH) | 20 000 |
| 11.18.073 | Determination of translocation of the BCL6 gene by fluorescent hybridization in situ (FISH) | 20 000 |
| 11.18.074 | Determination of the amplification of the CDK4 gene by fluorescent hybridization in situ (FISH) | 17 000 |
| 11.18.075 | Determination of the amplification of the MDM2 gene by fluorescent hybridization in situ (FISH) | 17 000 |
| 11.18.076 | Immunogymic examination of cervical cancer Cin-test (p16, Ki-67) | 5 500 |
| 11.18.078 | ASXL1 molecular genetic study, CEBPA, Dnmt3a, FLT3, IF1, IDH2, KIT, NPM1, RUNX1, SF3B1, Srsf2, Tet2, TP53, U2AF1, WT1, ZRSR2, Abl1 | 45 000 |
| 11.18.079 | Determination of deletion 17r by fluorescent hybridization in situ (FISH) | 17 000 |
| 11.18.080 | Molecular genetic study of mutations in the TP53 gene by NGS | 25 000 |
| 11.18.081 | The molecular genetic study of the mutation status of genes of variable areas of immunoglobulins (IgHV) | 19 000 |
| 11.18.082 | Molecular genetic study of mutations in the Pole gene | 12 000 |
| 11.18.083 | Molecular genetic study of translocations Alk gene (FISH) | 12 000 |
| 11.18.084 | Molecular genetic study of translocations of the ROS1 gene (FISH) | 12 000 |
| 11.18.085 | Molecular genetic study of inversion of the 3rd chromosome (EVI1, Mecom (3Q26)) Fish method | 17 000 |
| 11.18.086 | Immunohistochemical examination of biomaterial (1 antibody) | 3 000 |
Barefoot therapy
| The code | Designation | Price |
| 04.05.007 | BOS therapy (Treatment according to the biological feedback methodology), 1 session | 880 |
| 04.05.012 | The impact of a high-intensity pulsed magnetic field using biologically feedback by the BTL-6000 Super Inductive System | 770 |
| 04.05.011 | Restoration of fine motor skills and coordination with the assessment of capabilities using BOS (glove) | 770 |
| 04.05.016 | Correct functions correction using biologically feedback by the simulator Orthotent Cognitive | 550 |
| 04.05.003 | Correction of a violation of the motor function using biological feedback | 440 |
| 04.05.013 | Correction of a violation of the motor function using biological feedback by the simulator Balance Tutor | 990 |
| 04.05.015 | Correction of a motor function using computer technology using the Virtual Reality simulator Devirt | 990 |
| 04.05.002 | Mechanotherapy on mechanotherapeutic devices with a following drive in diseases of the central nervous system and brain | 550 |
| 04.05.005 | Mechanotherapy for simple mechanotherapeutic devices for diseases of the central nervous system and brain | 660 |
| 04.05.009 | Assessment and treatment of a speech therapy state of the individual (Bos psychological) (30 minutes) | 1 320 |
| 04.05.008 | Assessment and treatment of the psychological state of the individual (Bos psychological) (30 minutes) | 1 320 |
| 04.05.010 | Robotized complex (mechano and locomotor therapy) for the rehabilitation of the lower extremities (exoatlet) | 1 650 |
| 04.05.001 | Training with biological feedback on hemodynamic indicators | 440 |
| 04.05.006 | Training with biological feedback on hemodynamic indicators of diseases of the system of hematopoiesis and blood systems | 550 |
| 04.05.014 | Training with biological feedback on goniographic indicators (on the articular corner) for diseases of the central nervous system and the head | 880 |
| 04.05.004 | Training with biological feedback on a supporting reaction in diseases of the central nervous system and brain | 550 |

